Table 4.

Low-dose DT (25 ng/g): Density of type I or II HCs.

UTRICLE (Data for Figure 10N)
Genotype	Time	Type I HCs*	SIG. DIFFS. PER ONE-WAY ANOVA: HCI***	Type II HCs*	SIG. DIFFS. PER ONE-WAY ANOVA: HCII***	N	HCI: % of control**	HCII: % of control**
Wildtype (WT)**	70d pDT	93 ± 17	p ≤ 0.05 for DTR 14d; p ≤ 0.01 DTR for 140d; p ≤ 0.001 DTR for 42, 70, 445d	92 ± 21	p ≤ 0.01 for DTR 70d; p ≤ 0.001 for DTR 140, 445d; p ≤ 0.0001 for DTR 14, 42d	3	–	–
DTR	14d pDT	53 ± 14	p ≤ 0.05 WT	12 ± 17	p ≤ 0.0001 WT; p ≤ 0.05 for DTR 70, 445d; p ≥ 0.01 for 140d	3	57	13
	42d pDT	25 ± 10	p ≤ 0.001 WT	27 ± 11	p ≤ 0.0001 WT	3	27	29
	70d pDT	28 ± 9	p ≤ 0.001 WT	45 ± 4	p ≤ 0.01 WT	3	30	49
	140d pDT	38 ± 16	p ≤ 0.01 WT	46 ± 6	p ≤ 0.001 WT; p ≤ 0.05 DTR 14d	4	41	50
	445d pDT	24 ± 10	p ≤ 0.001 WT	42 ± 5	p ≤ 0.001 WT	3	26	46
AMPULLA (Data for Figure 10O)
Genotype	Time	Type I HCs*	SIG. DIFFS. PER ONE-WAY ANOVA: HCI***	Type II HCs*	SIG. DIFFS. PER ONE-WAY ANOVA: HCII***	N	HCI: % of control**	HCII: % of control**
Wildtype (WT)**	14d (n = 1) & 42d pDT (n = 2)	82 ± 9	p ≤ 0.01 for DTR 14, 42d; p ≤ 0.05 for DTR 170d	86 + 11	p ≤ 0.0001 for DTR 14, 42d; p ≤ 0.001 for DTR 170d	3	–	–
DTR	14d pDT	23 ± 11	p ≤ 0.01 for WT	9 + 6	p ≤ 0.0001 for WT	2	28	10
	42d pDT	27 ± 8	p ≤ 0.01 for WT	14 + 2	p ≤ 0.0001 for WT	3	33	16
	170d pDT	40 ± 13	p ≤ 0.05 for WT	22 + 5	p ≤ 0.001 for WT	2	48	26

* HCs per 10,000 μm² (Avg ± SD). *** Shows groups significantly different from the group in gray. Shading on left. ** WT controls received 25 ng/g DT.